Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

25 projects found matching your search criteria :

  1. Streptococcus suis: molecular comparison of human and animal invasive strains

    Call: OPUS 4 , Panel: NZ2

    Principal investigator: dr hab. Ewa Sadowy

    Narodowy Instytut Leków

  2. Clonal structure and mobilome of glycopeptide resistant Enterococcus faecalis

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: dr Ewa Wardal

    Narodowy Instytut Leków

  3. Influence of the route of administration of new psychoactive substances on their metabolic profile

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Magdalena Popławska

    Narodowy Instytut Leków

  4. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in Poland.

    Call: OPUS 4 , Panel: NZ6

    Principal investigator: prof. Marek Gniadkowski

    Narodowy Instytut Leków

  5. Epidemiology of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in Poland over the last deca...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Marek Gniadkowski

    Narodowy Instytut Leków

  6. Multidrug resistant Streptococcus pneumoniae invasive isolates of serotype 19A: a new epidemiological threat in Poland

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Anna Skoczyńska

    Narodowy Instytut Leków

  7. IDENTIFICATION AND STRUCTURAL STUDIES OF NEW PSYCHOACTIVE SUBSTANCES IN SYNTHETIC NARCOTICS OF LAST GENERATION USING ORG...

    Call: OPUS 5 , Panel: ST4

    Principal investigator: prof. Lech Kozerski

    Narodowy Instytut Leków

  8. Studies of alkylation mechanism of DNA oligomers using new Top I inhibitors from camptothecin family by physical organic...

    Call: OPUS 14 , Panel: ST4

    Principal investigator: prof. Lech Kozerski

    Narodowy Instytut Leków

  9. Epidemic clonal lineages of Enterobacteriales producing VIM-type carbapenemases in Poland, 2006-19.

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr Radosław Izdebski

    Narodowy Instytut Leków

  10. Characteristic of penicillin-resistant clinical isolates of Enterococcus faecalis

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: Iwona Gawryszewska

    Narodowy Instytut Leków

  11. Concomitant IDentification and Antibiotic REsistance profile of bacteria in one hour with an adaptive targeted single Ma...

    Call: JPIAMR2019 , Panel: NZ6

    Principal investigator: prof. Marek Tomasz Gniadkowski

    Narodowy Instytut Leków

  12. Yeast-based biosensors for the specific and accessible detection of pathogens and antimicrobial resistance

    Call: JPIAMR2019 , Panel: NZ6

    Principal investigator: dr Alicja Kuch

    Narodowy Instytut Leków

  13. Streptococci from mitis group: defining the boundary between pathogenic Streptococcus pneumoniae and other commensal spe...

    Call: HARMONIA 5 , Panel: NZ2

    Principal investigator: dr hab. Ewa Sadowy

    Narodowy Instytut Leków

  14. Mechanistic study on enantioseparations of the novel oxazolidinones

    Call: SONATA 6 , Panel: NZ7

    Principal investigator: dr Katarzyna Michalska

    Narodowy Instytut Leków

  15. Pharmacological potential of mistletoe (Viscum album L.) in the prevention of central nervous system disorders.

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Szurpnicka

    Narodowy Instytut Leków

  16. CHIRAL RHENIUM AND RHODIUM COMPLEXES OF ANTICANCER AND ANTIBACTERIAL ACTIVITY: SYNTHESIS, ACTIVITY, AND PHYSICOCHEMICAL ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Jan Dobrowolski

    Narodowy Instytut Leków

  17. Genomic epidemiology of Enterobacterales producing OXA-48-type carbapenemases in Poland, 2013-2023

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr hab. Radosław Izdebski

    Narodowy Instytut Leków

  18. Hospital Enterococcus faecium and Enterococcus faecalis with the vanB-mediated vancomycin resistance: epidemiology and b...

    Call: OPUS 26 , Panel: NZ2

    Principal investigator: prof. Ewa Sadowy

    Narodowy Instytut Leków

  19. The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines ...

    Call: PRELUDIUM 3 , Panel: NZ5

    Principal investigator: Małgorzata Milczarek

    Narodowy Instytut Leków

  20. Structure of Neisseria meningitidis serogroup B population in Poland, 2010-2014.

    Call: PRELUDIUM 4 , Panel: NZ7

    Principal investigator: Izabela Waśko

    Narodowy Instytut Leków

  21. Fentanyl opioid designer drugs: from molecular modeling to in vitro studies

    Call: OPUS 6 , Panel: ST4

    Principal investigator: prof. Joanna Sadlej

    Narodowy Instytut Leków

  22. Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Flis

    Narodowy Instytut Leków

  23. The multilocus sequence typing (MLST) scheme for Pseudomonas putida and molecular epidemiology of metallo-beta-lactamase...

    Call: PRELUDIUM 11 , Panel: NZ7

    Principal investigator: Paweł Urbanowicz

    Narodowy Instytut Leków

  24. Genomic analysis of invasive vancomycin-resistant Enterococcus faecium of VanA phenotype from intensive-care units in Po...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Ewa Wardal

    Narodowy Instytut Leków

  25. In search for molecular targets to overcome doxorubicin resistance in triple-negative breast cancer with the use of inno...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Anna Pogorzelska

    Narodowy Instytut Leków

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy